Calithera Biosciences: UCSF Spin-out Takes $40 Million First Round

An investor syndicate led by Morgenthaler Ventures has backed cancer drug researcher Calithera Biosciences Inc. with $40 million in Series A funding, intended to support development of small-molecule compounds that activate caspases.